All you need to know about CBG
Despite the fact that cannabis is a complex plant with more than 400 chemical entities, the cannabis industry is generally still focused on only two already known cannabinoids: THC and CBD, thus this does not mean that other cannabinoids are not finding their way in the cannabis market. One of them being cannabigerol CBG, the so-called minor cannabinoid, which is getting more and more attention. The cannabinoid experts began to monitor it more closely because of its antibacterial, antimicrobial and anti-inflammatory properties. The pharmacological effects of CBG described in the scientific literature include: anti-fungal, anti-insect and anti-inflammatory activity; neuroprotective activity; stimulation of appetite, and enhancement of the death process of cancer cell.
What science says about CBG
Cannabigerol CBG interacts with the CB1 and CB2 receptors, inhibiting the intoxicating effects of THC. It also demonstrated an ability to increase anandamide, commonly referred to as the “bliss molecule,” an endogenous cannabinoid that helps regulate a wide range of bodily functions, including appetite, sleep, mood, and the immune system. More research is needed to fully understand what CBG has to offer from a medicinal standpoint, but existing studies have already presented several reasons to be optimistic about the therapeutic potential of CBG.
What science says about CBG
Cannabigerol CBG interacts with the CB1 and CB2 receptors, inhibiting the intoxicating effects of THC. It also demonstrated an ability to increase anandamide, commonly referred to as the “bliss molecule,” an endogenous cannabinoid that helps regulate a wide range of bodily functions, including appetite, sleep, mood, and the immune system. More research is needed to fully understand what CBG has to offer from a medicinal standpoint, but existing studies have already presented several reasons to be optimistic about the therapeutic potential of CBG.
Inflammation
In a 2007 study published in the Journal of Dermatological Science, researchers found that CBG, along with other cannabinoids, has the potential to treat inflammation caused by psoriasis, a chronic skin condition caused by an overactive immune system. In 2013 animal study, published in Biochemical Pharmacology, CBG also demonstrated the ability to reduce colon inflammation in rats, suggesting that CBG may be an effective treatment for inflammatory bowel disease (IBD) symptoms.
